Kura Oncology (KURA) Return on Equity [ROE] (2024 - 2026)
Kura Oncology (KURA) recorded Return on Equity [ROE] of -379.72% in Q2 2026, down 321.45 percentage points from -58.26% a year earlier and down 170.81 percentage points from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Return on Equity [ROE] (2024 - 2026) Analysis & Trends
For FY2025, Kura Oncology reported Return on Equity [ROE] of -94.82%, down 51.91 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three straight years, with a three-year change of -65.51 percentage points (FY2022 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -42.91% in FY2024 (-5.57 pp), -37.34% in FY2023 (-8.03 pp) and -29.31% in FY2022.
- The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q1 2024.
- On a year-over-year basis, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -115.54 percentage points over the last six quarters.
- Per Business Quant, the preceding three quarters came in at -208.90% (Q1 2026), -133.76% (Q4 2025) and -78.41% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.97% |
| 10 | Kura Oncology | 947.36 Mn | 947.36 Mn | 20.63 Mn | -379.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -379.72% |
| Mar 31, 2026 | -208.90% |
| Dec 31, 2025 | -133.76% |
| Sep 30, 2025 | -78.41% |
| Jun 30, 2025 | -58.26% |
| Mar 31, 2025 | -46.24% |
| Dec 31, 2024 | -41.07% |
| Sep 30, 2024 | -34.80% |
| Jun 30, 2024 | -20.68% |
| Mar 31, 2024 | -10.99% |
API Access
Kura Oncology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();